Randomized trial to assess efficacy and safety of an add-on treatment with zonisamide in adults with focal epileptic seizures with or without secondary generalization.
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2014
At a glance
- Drugs Zonisamide (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 18 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 Jul 2008 Planned patient numbers identified as 200 by ClinicalTrials.gov.
- 18 Jul 2008 The expected completion date for this trial has been identified as Jul 2008, as reported by ClinicalTrials.gov.